Equasens Announces Financial Calendar for FY 2026
- Financial Calendar Release: Equasens announces its financial calendar for FY 2026, with 2025 annual revenue set to be released on February 5, 2026, reflecting the company's commitment to transparency and aiming to bolster investor confidence.
- Earnings Report Schedule: The 2025 annual results will be published on March 30, 2026, followed by the Q1 2026 revenue report, which is expected to provide critical performance metrics that will help the market assess the company's future growth potential.
- Annual General Meeting Date: The company plans to hold its Annual General Meeting on June 25, 2026, aiming to enhance communication with shareholders and promote corporate governance and transparency.
- Commitment to Sustainable Development: As a leader in digital healthcare solutions, Equasens is dedicated to supporting healthcare professionals through regular financial disclosures, further solidifying its leadership position in the industry.
Trade with 70% Backtested Accuracy
Analyst Views on EQS
About EQS
About the author


Equus Total Return, Inc. Funding Announcement: Equus announced that its subsidiary, Morgan E&P, has secured a $3 million term loan to fund drilling operations in the Bakken Shale formation, aiming to enhance production and cash flow by developing existing non-producing wells.
Strategic Development Plans: The funding will allow Morgan to accelerate development opportunities in both operated and non-operated acreage, with expectations of increasing production volumes and strengthening Equus' energy portfolio strategy in one of North America's key oil-producing regions.

Equus Total Return, Inc. Compliance Issue: The company received a notice from the NYSE for not meeting the minimum average closing price requirement of $1.00 for its common stock over a 30-day period, but this deficiency does not currently affect its listing or trading status.
Plans to Regain Compliance: Equus intends to notify the NYSE by May 25, 2025, of its plan to address the stock price deficiency, potentially through a reverse stock split, and has a six-month period to regain compliance with the NYSE's standards.

New Appointments at Equus Total Return, Inc.: Fraser Atkinson has been appointed as the independent Chairman of the Board and John J. May as an independent director, effective immediately. Both will serve on various committees within the Fund.
John J. May's Background: Mr. May brings over 50 years of experience as a Chartered Accountant and has held significant roles in public and private companies, particularly in mining, energy, and oil and gas sectors. He is also involved with lobbying groups representing small and medium-sized businesses in the UK.
Financial Performance: Equus Total Return, Inc. reported a decrease in net assets to $40.2 million and a decline in net asset value per share from $3.66 to $2.96 as of September 30, 2024, primarily due to decreases in the fair value of its holdings in Morgan E&P and Equus Energy.
Market Influences: The declines in fair value were attributed to a significant drop in oil prices and decreased production from operational wells, with specific losses of $7.0 million for Morgan E&P and $2.0 million for Equus Energy during the third quarter of 2024.



